Article Information
vol. 5 no. 5, 636-648
- Received November 28, 2011
- Accepted June 10, 2012
- Published online August 21, 2012.
Article Versions
- Previous version (July 5, 2012 - 09:27).
- You are viewing the most recent version of this article.
Author Information
- Cristina Martínez-García1,
- Adriana Izquierdo1,
- Vidya Velagapudi2,
- Yurena Vivas1,
- Ismael Velasco1,
- Mark Campbell3,
- Keith Burling3,
- Fernando Cava4,
- Manuel Ros1,
- Matej Orešič2,
- Antonio Vidal-Puig3 and
- Gema Medina-Gomez1,*
- 1Universidad Rey Juan Carlos, Dpto. de Bioquímica, Fisiología y Genética Molecular, Avda. de Atenas s/n. 28922, Alcorcón, Madrid, Spain
- 2VTT Technical Research Centre of Finland, Tietotie 2, Espoo, PO Box 1500, FIN-02044 VTT, Finland
- 3University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Level 4, Box 289, Addenbrookes Hospital, Hills Road, Cambridge, CB2 OQQ, UK
- 4Área de Laboratorio – Hospital Universitario Fundación Alcorcón, C/Budapest 1. 28922, Alcorcón, Madrid, Spain
- ↵* Author for correspondence (gema.medina{at}urjc.es)
Article usage
Usage statistics are calculated at the beginning of each month for the previous month.
Statistics from Altmetric.com
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Final call: funded Workshop spaces available for early-career researchers
Don’t miss out on July’s Workshop on ‘Inflammaging and Regeneration: Pain or Partnership’, organised by Helen Blau, Stanford University, USA and Nadia Rosenthal, The Jackson Laboratory, USA. Explore novel techniques and innovations alongside leading experts and share ideas in a stimulating environment. The registration deadline is 28 February – find out more and how to apply.
Meet the editors
Catch up with Julija Hmeljak, Reviews Editor, at conferences this coming month. Say hello, ask any questions, and find out more about the journal and The Company of Biologists.
Keystone – Brain Therapeutics: Disruptive Technologies and Opportunities
Santa Fe, 16-19 February
Cell Symposia – Gene- and Cell-Based Therapies: CRISPR, Stem Cells, and Beyond
San Francisco, 2-4 March
Stefan Galander, Reviews Editor, will also be at EMBL's Advances in Stem Cells and Regenerative Medicine conference in Heidelberg, 8-11 March.
Hear from this month’s first authors! Eric Clark, Sarah Colijn, Wedad Fallatah, Tara Smith and Cathryn Ugalde talk about their papers and life in science.
Read the latest Editorial, which discusses how blood disorders research is providing a blueprint for successful translation from disease modelling to clinically viable treatment.
Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
Congenital generalised lypodystrophy patients with BSCL2 mutations develop severe metabolic complications, including hepatic steatosis. But Rochford et al. show that it does not play a cell-autonomous role in regulating lipid accumulation.